Overview Fundamentals API Earnings EOD API Sample Code Pricing

Anixa Biosciences Inc (ANIX NASDAQ) stock market data APIs

$3.6 0.15(4.3%) as of November 4, 2024
Price chart is built with Anychart

Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR- T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer " primarily triple negative breast cancer (TNBC), the lethal form of the disease, as well as a vaccine to prevent ovarian cancer. Its vaccine technologies focus on immunizing against retired proteins that found to be expressed in certain forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Anixa Biosciences Inc Financial Data Overview

3.45
3.6
-
3.6407
3.41
2.145-5.13
117 M
32 180 K
0
-0.1
0.863
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ANIX',
Type: 'Common Stock',
Name: 'Anixa Biosciences Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BG3J79',
ISIN: NULL,
CUSIP: NULL,
CIK: '715446',
EmployerIdNumber: '11-2622630',
FiscalYearEnd: 'October',
IPODate: '1987-01-01',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Anixa Biosciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -13 097 416
  • Earnings Per Share -0.37
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Anixa Biosciences Inc Earnings via APIs

  • Latest Release 2024-09-06
  • EPS/Forecast -0.09

Get Anixa Biosciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com